ADUS stock forecast, quote, news & analysis
Addus HomeCare Corp is engaged in the provision of in-home care services... Show more
Addus HomeCare (ADUS) Stock Analysis: Diversified Home Care Segments Anchor a Steady Range
Key Takeaways
- Addus HomeCare shares have traded in a relatively narrow band over the trailing 30 days, rising roughly 0.7% from about $117.07 to near $117.92.
- The stock dipped toward the $110 level in late September and early October before recovering, signaling range-bound behavior rather than a sharp directional move.
- Addus operates across three complementary segments — personal care, home health, and hospice — which diversifies its revenue base within the broader home-based care industry.
- Long-term demand tailwinds, including an aging population and a shift toward lower-cost, home-based care settings, remain central to the investment narrative.
- Reimbursement trends, labor costs, and acquisition activity are among the key swing factors investors are watching.
Current Market Snapshot
Addus HomeCare stock has been consolidating in a relatively stable trading range in recent weeks. After trading near $117 in mid-September, the shares eased to roughly the $110 area by the end of the month before recovering to approximately $117.92, leaving the stock essentially flat over the trailing 30-day period. This pattern reflects a market that has not yet assigned a decisive new direction to the shares, with buyers stepping in on pullbacks while upside momentum remains measured.
Within the broader healthcare landscape, home-based care providers occupy a distinct position: demand for their services tends to be steadier and less discretionary than many other healthcare segments, but margins remain sensitive to reimbursement policy and wage inflation. Against that backdrop, Addus has maintained a reputation as one of the more diversified operators in the space, which has helped temper volatility relative to more narrowly focused peers.
Addus HomeCare (ADUS) Business Overview and Competitive Position
Addus HomeCare Corporation, headquartered in Frisco, Texas, is a leading provider of home-based care services in the United States. The company operates through three primary segments: personal care services, which represent its largest revenue source; home health; and hospice. Personal care involves assistance with daily living activities for elderly and disabled individuals, while home health and hospice add skilled clinical and end-of-life services, respectively.
This multi-segment structure is a key competitive differentiator. By spanning both non-clinical and clinical care, Addus can serve patients across a broader continuum and pursue cross-referral opportunities between its business lines. The company has also grown historically through a combination of organic expansion and strategic acquisitions, steadily extending its geographic footprint and patient base. Because a meaningful portion of its services is reimbursed through Medicaid, Medicare, and managed-care payors, investors follow Addus closely as a gauge of both demographic-driven healthcare demand and evolving government reimbursement policy.
Recent Developments Driving ADUS
Over the past month, Addus shares have been shaped more by sector-level forces than by a single company-specific catalyst. The late-September pullback toward the $110 mark coincided with broader softness across healthcare services, as investors weighed concerns around labor costs and the direction of government reimbursement. The subsequent recovery into the mid-$110s reflected renewed buying interest, consistent with the stock's longer-running pattern of attracting demand on dips.
The home care industry continues to draw investor attention for structural reasons. An aging U.S. population and a preference for lower-cost, community-based care settings support steady service volumes. At the same time, the sector faces persistent pressures tied to caregiver recruitment and retention, wage inflation, and periodic uncertainty around Medicaid and Medicare payment rates. For Addus specifically, the market also monitors the pace and discipline of its acquisition strategy, which has historically been a meaningful driver of growth but carries integration and leverage considerations.
Trending AI Robots
Tickeron's Trending AI Robots page showcases a curated selection of AI-powered trading bots that currently rank among the platform's most relevant and top-performing strategies. While Tickeron offers hundreds of AI trading bots that collectively trade thousands of tickers, only those meeting the platform's performance and relevance criteria appear in this featured section. The bots span a range of approaches, timeframes, and performance metrics, allowing traders to explore strategies that align with their own objectives and risk tolerance. For those interested in automated, data-driven approaches to the markets, the Trending AI Robots page offers a practical starting point for discovering active strategies.
2026 Outlook and What Investors Should Watch
Looking ahead, several factors are likely to shape the trajectory of Addus HomeCare shares. Reimbursement developments remain a central focus, as changes to Medicaid and Medicare payment rates can directly influence margins across the company's segments. Labor dynamics are equally important; caregiver shortages and wage pressure have the potential to constrain growth and compress profitability if not managed effectively.
Investors should also monitor the company's acquisition pipeline and integration progress, as well as broader demographic trends that underpin long-term demand for home-based care. Managed-care and payor relationships, regulatory shifts in home health and hospice, and the company's ability to sustain organic volume growth round out the key watch items. While the fundamentals supporting home-based care remain intact, near-term performance will likely depend on how these operational and policy variables evolve.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
ADUS in upward trend: price rose above 50-day moving average on October 20, 2026
ADUS moved above its 50-day moving average on October 20, 2026 date and that indicates a change from a downward trend to an upward trend. In 44 of 56 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are 79%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ADUS's RSI Indicator exited the oversold zone, 17 of 22 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 77%.
The Momentum Indicator moved above the 0 level on October 08, 2026. You may want to consider a long position or call options on ADUS as a result. In 63 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 74%.
The Moving Average Convergence Divergence (MACD) for ADUS just turned positive on October 08, 2026. Looking at past instances where ADUS's MACD turned positive, the stock continued to rise in 36 of 47 cases over the following month. The odds of a continued upward trend are 77%.
Following a +1.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADUS advanced for three days, in 211 of 319 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
Bearish Trend Analysis
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The 10-day moving average for ADUS crossed bearishly below the 50-day moving average on September 23, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 58%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADUS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 62%.
ADUS broke above its upper Bollinger Band on October 14, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for ADUS entered a downward trend on October 12, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Seasonality Score of 7 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. ADUS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 59 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is 70 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 76 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.918) is normal, around the industry mean (204.137). P/E Ratio (20.336) is within average values for comparable stocks, (19.387). Projected Growth (PEG Ratio) (0.983) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.095) among similar stocks. P/S Ratio (1.483) is also within normal values, averaging (2.688).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of home and community based services
Industry HospitalNursingManagement